1CM
NTUS

1492 Capital Management’s Natus Medical Inc NTUS Stock Holding History

1492 Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,137
Closed -$905K – 106
2017
Q3 		$905K Buy
+24,137
New +$852K 0.8% 39

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

1492 Capital Management's NTUS Position: Q4 2017 in Review

1492 Capital Management sold out of Natus Medical Inc (NTUS) in Q4 2017, closing a stake of 24,137 shares — an estimated $905K sold.

1492 Capital Management first reported a position in NTUS in Q3 2017 and held it in 1 quarter. The position peaked at $905K in Q3 2017. 214 funds tracked by Wall St. Rank hold NTUS as of Q4 2017.

  • 1492 Capital Management reported no remaining Natus Medical Inc position as of Q4 2017 after selling out during the quarter.
  • 1492 Capital Management sold 24,137 Natus Medical Inc shares in Q4 2017, an estimated $905K.
  • 1492 Capital Management first reported a position in Natus Medical Inc in Q3 2017 and held it in 1 quarter.
  • 1492 Capital Management's Natus Medical Inc position peaked at $905K in Q3 2017.
  • 214 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2017.

Based on 1492 Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.